论文部分内容阅读
目的探讨前列地尔联合恩替卡韦治疗慢性乙型肝炎的临床疗效。方法选择宿迁市钟吾医院2013—2014年收治的慢性乙型肝炎患者120例,随机分为治疗组60例和对照组60例。对照组给予恩替卡韦口服、甘草酸二胺、维生素C、肌苷等治疗,治疗组在对照组基础上给予前列地尔治疗。比较两组的症状消失时间及总胆红素(TBi L)、丙氨酸氨基转移酶(ALT)、天冬氨基转移酶(AST)、清蛋白(ALB)水平。结果观察组腹胀、乏力、皮肤瘙痒消失时间均短于对照组,差异有统计学意义(P<0.05)。两组恶心、食欲不振消失时间比较,差异无统计学意义(P>0.05)。治疗2周时观察组TBi L、ALT、AST水平低于对照组,差异有统计学意义(P<0.05),治疗4周时观察组TBi L水平低于对照组,差异有统计学意义(P<0.05)。结论前列地尔联合恩替卡韦治疗慢性乙型肝炎的临床疗效确切,可缩短症状消失时间,有效改善肝功能。
Objective To investigate the clinical efficacy of alprostadil in combination with alprostadil for the treatment of chronic hepatitis B. Methods 120 cases of chronic hepatitis B patients admitted to Zhongwu Hospital of Suqian City from 2013 to 2014 were randomly divided into treatment group (60 cases) and control group (60 cases). The control group was treated with oral entecavir, diammonium glycyrrhizinate, vitamin C and inosine, and the treatment group was treated with alprostadil on the basis of the control group. The time of symptom disappearance and the levels of total bilirubin (TBiL), alanine aminotransferase (ALT), aspartate aminotransferase (AST) and albumin (ALB) were compared between the two groups. Results The abdominal distension, fatigue and skin pruritus disappeared in the observation group were shorter than those in the control group (P <0.05). Two groups of nausea, loss of appetite disappear time comparison, the difference was not statistically significant (P> 0.05). The level of TBiL, ALT and AST in the observation group was lower than that in the control group at 2 weeks after treatment (P <0.05), and the TBiL level in the observation group was lower than that of the control group at 4 weeks <0.05). Conclusion Alprostadil combined entecavir treatment of chronic hepatitis B clinical curative effect is exact, can shorten the disappearance of symptoms, effectively improve liver function.